Indication

Prostanor is indicated for the treatment of the signs and symptoms of Benign Prostatic Hyperplasia (BPH).


Dosage & Administration

Prostanor 4 mg: Prostanor 4 mg capsules taken orally once daily with a meal for those with moderate renal impairment [Creatinine Clearance (CCr) 30-50 ml/min].

Prostanor 8 mg: Prostanor 8 mg capsules taken orally once daily with a meal.

 

Dose adjustment for Hepatic and Renal Impaired patients

Renal Impairment: Silodosin should be reduced to 4 mg per day in patients with moderate Renal Impairment. Silodosin is contraindicated in patients with severe Renal Impairment (CCr < 30 ml/min).

Hepatic Impairment: No dosing adjustment is required in patients with mild or moderate Hepatic Impairment. Silodosin is contraindicated in patients with severe Hepatic Impairment (Child-Pugh score > 10).


Precautions

Postural hypotension with or without symptoms (e.g. dizziness) may develop when beginning Silodosin treatment. Silodosin should not be used in combination with other alpha-blockers. Inform patients planning cataract surgery to notify their ophthalmologist that they are taking Silodosin because of the possibility of Intraoperative Floppy Iris Syndrome (IFIS)

 

Use in special group

In Pregnancy: Silodosin is not indicated for use in women.

Usage in Pediatric patient: Silodosin is not indicated for use in pediatric patients.


Product Details


Related Products

CK

Potassium Citrate 1.5 g & Citric Acid Monohydrate 250 mg/ 5 ml
Urological

M-beg

Mirabegron
Urological

Solurin

Solifenacin Succinate
Urological